Is neutropenic fever an obstacle to effective stem cell harvesting?

INTRODUCTION: Autologous stem cell transplantation (ASCT) is a well-established consolidation treatment for many hematologic cancers which delivers prolonged survival. A subset of patients’ adequate stem cell harvest is not achievable with a solitary use of granulocyte colony-stimulating agents (G-C...

Full description

Saved in:
Bibliographic Details
Main Authors: Semih Başcı, Ersin Bozan, Samet Yaman, Bahar Uncu Ulu, Mehmet Bakırtaş, Tuğçe Nur Yiğenoğlu, Ali Kılınç, Nurgül Özcan, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:https://journals.lww.com/10.4103/ajts.ajts_152_21
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593718730817536
author Semih Başcı
Ersin Bozan
Samet Yaman
Bahar Uncu Ulu
Mehmet Bakırtaş
Tuğçe Nur Yiğenoğlu
Ali Kılınç
Nurgül Özcan
Mehmet Sinan Dal
Merih Kızıl Çakar
Fevzi Altuntaş
author_facet Semih Başcı
Ersin Bozan
Samet Yaman
Bahar Uncu Ulu
Mehmet Bakırtaş
Tuğçe Nur Yiğenoğlu
Ali Kılınç
Nurgül Özcan
Mehmet Sinan Dal
Merih Kızıl Çakar
Fevzi Altuntaş
author_sort Semih Başcı
collection DOAJ
description INTRODUCTION: Autologous stem cell transplantation (ASCT) is a well-established consolidation treatment for many hematologic cancers which delivers prolonged survival. A subset of patients’ adequate stem cell harvest is not achievable with a solitary use of granulocyte colony-stimulating agents (G-CSF). Generally, chemomobilization is employed for patients failing G-CSF and its most feared complication febrile neutropenia (FN). MATERIALS AND METHODS: Here, we aimed to investigate the impact of the FN in chemomobilization on apheresis outcomes and engraftment. One hundred and eighty-three patients with the diagnosis of lymphoma or myeloma who underwent chemomobilization between 2015 and 2020 were included in the study. RESULTS: Forty-three patients experienced FN. All patients received G-CSF. All myeloma patients were mobilized with 4 g/m2 cyclophosphamide, but it was heterogeneous for lymphoma patients. The precollection blood counts, harvested CD34+ hematopoietic stem cells (HSCs)/kg, apheresis count, and engraftment durations were recorded. Preapheresis leukocyte and platelet were lower in the FN group (P = 0,004 and P = 0,001). Peripheral CD34 HSCs and total harvested CD34 HSCs were similar among groups (P = 0.25 and P = 0.9). More apheresis was needed in the FN group, but it was not significant (P = 0.07). Undergoing ASCT was similar (P = 0.7); however, platelet and neutrophil engraftment durations were slower in the FN group (P = 0.05 and P = 0.001). CONCLUSION: Harvesting sufficient CD34+ HSCs from patients with FN is still feasible; however, FN treatment should begin promptly, and further apheresis sessions may be required.
format Article
id doaj-art-04ff07c0364a487b91ff284d0e8e1c59
institution Kabale University
issn 0973-6247
1998-3565
language English
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj-art-04ff07c0364a487b91ff284d0e8e1c592025-01-20T09:22:19ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652024-01-01181212610.4103/ajts.ajts_152_21Is neutropenic fever an obstacle to effective stem cell harvesting?Semih BaşcıErsin BozanSamet YamanBahar Uncu UluMehmet BakırtaşTuğçe Nur YiğenoğluAli KılınçNurgül ÖzcanMehmet Sinan DalMerih Kızıl ÇakarFevzi AltuntaşINTRODUCTION: Autologous stem cell transplantation (ASCT) is a well-established consolidation treatment for many hematologic cancers which delivers prolonged survival. A subset of patients’ adequate stem cell harvest is not achievable with a solitary use of granulocyte colony-stimulating agents (G-CSF). Generally, chemomobilization is employed for patients failing G-CSF and its most feared complication febrile neutropenia (FN). MATERIALS AND METHODS: Here, we aimed to investigate the impact of the FN in chemomobilization on apheresis outcomes and engraftment. One hundred and eighty-three patients with the diagnosis of lymphoma or myeloma who underwent chemomobilization between 2015 and 2020 were included in the study. RESULTS: Forty-three patients experienced FN. All patients received G-CSF. All myeloma patients were mobilized with 4 g/m2 cyclophosphamide, but it was heterogeneous for lymphoma patients. The precollection blood counts, harvested CD34+ hematopoietic stem cells (HSCs)/kg, apheresis count, and engraftment durations were recorded. Preapheresis leukocyte and platelet were lower in the FN group (P = 0,004 and P = 0,001). Peripheral CD34 HSCs and total harvested CD34 HSCs were similar among groups (P = 0.25 and P = 0.9). More apheresis was needed in the FN group, but it was not significant (P = 0.07). Undergoing ASCT was similar (P = 0.7); however, platelet and neutrophil engraftment durations were slower in the FN group (P = 0.05 and P = 0.001). CONCLUSION: Harvesting sufficient CD34+ HSCs from patients with FN is still feasible; however, FN treatment should begin promptly, and further apheresis sessions may be required.https://journals.lww.com/10.4103/ajts.ajts_152_21autologous stem cell transplantationchemomobilizationfebrile neutropenianeutropenic feverstem cell mobilization
spellingShingle Semih Başcı
Ersin Bozan
Samet Yaman
Bahar Uncu Ulu
Mehmet Bakırtaş
Tuğçe Nur Yiğenoğlu
Ali Kılınç
Nurgül Özcan
Mehmet Sinan Dal
Merih Kızıl Çakar
Fevzi Altuntaş
Is neutropenic fever an obstacle to effective stem cell harvesting?
Asian Journal of Transfusion Science
autologous stem cell transplantation
chemomobilization
febrile neutropenia
neutropenic fever
stem cell mobilization
title Is neutropenic fever an obstacle to effective stem cell harvesting?
title_full Is neutropenic fever an obstacle to effective stem cell harvesting?
title_fullStr Is neutropenic fever an obstacle to effective stem cell harvesting?
title_full_unstemmed Is neutropenic fever an obstacle to effective stem cell harvesting?
title_short Is neutropenic fever an obstacle to effective stem cell harvesting?
title_sort is neutropenic fever an obstacle to effective stem cell harvesting
topic autologous stem cell transplantation
chemomobilization
febrile neutropenia
neutropenic fever
stem cell mobilization
url https://journals.lww.com/10.4103/ajts.ajts_152_21
work_keys_str_mv AT semihbascı isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT ersinbozan isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT sametyaman isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT baharuncuulu isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT mehmetbakırtas isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT tugcenuryigenoglu isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT alikılınc isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT nurgulozcan isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT mehmetsinandal isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT merihkızılcakar isneutropenicfeveranobstacletoeffectivestemcellharvesting
AT fevzialtuntas isneutropenicfeveranobstacletoeffectivestemcellharvesting